First Tracks Biotherapeutics, Inc. (TRAX)
41.86
-2.88
(-6.44%)
USD |
NASDAQ |
Aug 28, 16:00
41.64
-0.22
(-0.53%)
After-Hours: 20:00
First Tracks Biotherapeutics Price to Book Value : 8.777 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 8.777 |
| August 27, 2026 | 9.380 |
| August 26, 2026 | 9.265 |
| August 25, 2026 | 9.458 |
| August 24, 2026 | 9.074 |
| August 21, 2026 | 9.039 |
| August 20, 2026 | 8.785 |
| August 19, 2026 | 9.540 |
| August 18, 2026 | 9.200 |
| August 17, 2026 | 9.141 |
| August 14, 2026 | 9.234 |
| August 13, 2026 | 9.232 |
| August 12, 2026 | 9.672 |
| August 11, 2026 | 9.802 |
| August 10, 2026 | 10.05 |
| August 07, 2026 | 9.504 |
| August 06, 2026 | 9.50 |
| August 05, 2026 | 9.844 |
| August 04, 2026 | 9.647 |
| August 03, 2026 | 9.678 |
| July 31, 2026 | 9.234 |
| July 30, 2026 | 10.02 |
| July 29, 2026 | 8.779 |
| July 28, 2026 | 8.774 |
| July 27, 2026 | 8.812 |
| Date | Value |
|---|---|
| July 24, 2026 | 7.447 |
| July 23, 2026 | 7.892 |
| July 22, 2026 | 8.003 |
| July 21, 2026 | 7.835 |
| July 20, 2026 | 7.730 |
| July 17, 2026 | 7.656 |
| July 16, 2026 | 7.592 |
| July 15, 2026 | 7.575 |
| July 14, 2026 | 7.206 |
| July 13, 2026 | 7.340 |
| July 10, 2026 | 7.598 |
| July 09, 2026 | 6.793 |
| July 08, 2026 | 4.355 |
| July 07, 2026 | 4.147 |
| July 06, 2026 | 4.202 |
| July 02, 2026 | 4.046 |
| July 01, 2026 | 3.898 |
| June 30, 2026 | 4.218 |
| June 29, 2026 | 2.305 |
| June 26, 2026 | 2.172 |
| June 25, 2026 | 2.218 |
| June 24, 2026 | 2.262 |
| June 23, 2026 | 2.410 |
| June 22, 2026 | 2.483 |
| June 18, 2026 | 2.361 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Forte Biosciences, Inc. | 8.580 |
| ACADIA Pharmaceuticals, Inc. | 3.835 |
| Agenus, Inc. | -- |
| Alnylam Pharmaceuticals, Inc. | 23.42 |
| Amgen, Inc. | 20.00 |
Price to Book Value Related Metrics
| Price | 41.86 |
| Earnings Yield | -11.81% |
| Market Cap | 1.481B |